US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 6.240
  • +0.070+1.13%
Close Feb 14 16:00 ET
  • 6.310
  • +0.070+1.12%
Pre 04:13 ET
279.48MMarket Cap-11.56P/E (TTM)

Y-mAbs Therapeutics Key Stats

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 24.373M--
--2024/Q4-- / 26.701M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--
May 7, 20242024/Q119.931M / 22.220M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 24.373M--
--2024/Q4-- / 26.701M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--
May 7, 20242024/Q119.931M / 22.220M--

Unlock Free Earnings Estimates

Y-mAbs Therapeutics Earnings Reports

Read more

Trending Stocks

Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More